Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO
Nicola A. Hanania(Baylor College of Medicine), Thomas B. Casale(University of South Florida), Bradley E. Chipps, Bongin Yoo, Noelle M. Griffin(Freenome (United States)), Ahmar Iqbal(Johns Hopkins University)
Cited by 70
Related Papers
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
|Journal of Allergy and Clinical Immunology|2010|1.8k
Lebrikizumab Treatment in Adults with Asthma
|New England Journal of Medicine|2011|1.5k
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
|Journal of Allergy and Clinical Immunology|2011|1.2k